Member Info for Tekked

Quite incredible speed to sentiment return after a while to react. Feels like the market has confidence on delivery for the whole portfolio with how well Belluscara has already delivered. Hopefully things will really start to ramp up now... afterall would not have seemed possible 6 months ago. Since then FDA clearance for Bell, big increase in Tek % ownership, Lucyd moving at speed. Exciting times :)

Suggests he might have been worried by all the accusations of dodgy dealings to feel the need to do it - what really was the point. Either way the facts are he's made a huge amount off the back of PIs, again, with the latest needless dilution designed to give him access to repeat the manipulation again. Doubt the 2.5m gets spent

Totally agree, this isn't the kind of company you invest in if you've got health issues. Traders paradise

It's already 30P on yesterday's share value with the announced 25% dilution. Complete mugging, why not do this 3 months ago when there was greater need and market interest? Too late. After seeing most of my profit wiped out over the last 6 months, pleased to say goodbye to this shoddy run outfit. GLA that still hold

Spent a good 15 mins from 8am trying to get a price, first time was 2.08p. Doubt anyone on here managed under 2p.

After nearly 150% rise from recent lows to that low impact rns, unsurprising drop this morning. Bizarre price action over the last two weeks. Hopefully something that can back up the price up coming soon

What I can tell Walkers have cut their holding in half roughly

After the 10P placing some 3-4 months ago I was adamant I'd sell the lot on reaching 20p in the future. Didn't expect it so soon but with the recent Lucyd revenue news, Belluscara's strong start I'm staying put. With the firmer valuations on those two, Guident and Salarius doing similar would see some real growth

The business is doing a lot well, if they continue to grow and retain clients at the current rate there'll be nothing to worry about. My only concern is whether there's enough big clients keen to invest in their brand protection, but given customer reviews and appetite to renew, that should come

Exactly, pure tax play...still has a huge amount of shares. Would be more worried about any further dilution to replace what he’s sold off. Not sure what he has outstanding he can exercise.

Lot of warrants exercised just announced, anyone any idea how many are still outstanding? Company's making great progress, hardly surprising to see them taken up at 1p a share

If you tell it how it is, why always commenting with a negative bottom line? Agree the rampers are OTT particularly on this board, but for some they're excited on the potential. I'm still invested and can see growth from the stock, or I wouldn't be interested enough to post on these boards.
Whether it's aimed against rampers / BRH, bottom line is you don't like to keep a level head in what you think of the stock, happier to focus on being an anti-ramper which makes it scream BUY

big rise = traders, low mcap, highly volatile, easy pickings for some with influx of new buyers... even with the spread

Lowest was 58 since the drop?

Spread - maybe to sell, not to buy. Can understand the urgency at that price for Belluscara shares uptake, in hindsight the bigger placing for furthering the rest of the portfolio would have been done 4 months ago. Poor planning and haste on the dilution to further the others where they could have probably brought in £3m for growth rather than the £2.5m

Although it stinks, it is the time to be buying. You can even top up without the OTT spread

Why £2.5m for the other businesses would be good to know specifically, from £0.38m 4 months later - another q&a would be useful if there would be some insight given. Having listened to the last it was complete waffle though.

Sure it could turn out to be good value, but I now have no idea what timelines to expect for returns that may never come if the insiders are always one step ahead

Think you’re right Seaman, people generally criticise aim but in my 30 plus strong portfolio this has been the worst performer in the last year, even worse than Verditek. When over 2/3 of the whopping placing was to further the fancy new salaries in the other non-revenue driving businesses. Certainly won’t be recommending this anymore but also know most long term offers will want out in the next couple of weeks so best to hold

Yep, running theme of a juicy discount to institutional investors. Sure they could have reduced the dilution offering out at 12p a share but not in the interests I guess? Next 20p pop I’m out

Indeed, interesting buys and SP movement today, very out of the blue. Hopefully something coming in the near future to back in up